Sotera Health Company (NASDAQ:SHC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Sotera Health Company (NASDAQ:SHC) has earned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $17.20.

SHC has been the topic of several recent analyst reports. Weiss Ratings reissued a “sell (d+)” rating on shares of Sotera Health in a research note on Friday. Barclays lifted their target price on Sotera Health from $17.00 to $19.00 and gave the company an “overweight” rating in a research note on Thursday, October 2nd. Finally, Wall Street Zen raised Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 16th.

Insider Buying and Selling at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 8,000,000 shares of Sotera Health stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $15.11, for a total transaction of $120,880,000.00. Following the transaction, the director owned 41,215,301 shares of the company’s stock, valued at $622,763,198.11. The trade was a 16.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Pincus & Co. Warburg sold 12,000,000 shares of Sotera Health stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $15.11, for a total value of $181,320,000.00. Following the transaction, the director directly owned 61,822,952 shares in the company, valued at approximately $934,144,804.72. This trade represents a 16.26% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 20,126,611 shares of company stock valued at $304,273,888 in the last 90 days. 47.55% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Sotera Health

A number of hedge funds have recently modified their holdings of the stock. Arizona State Retirement System increased its stake in shares of Sotera Health by 1.4% in the third quarter. Arizona State Retirement System now owns 46,183 shares of the company’s stock worth $726,000 after acquiring an additional 621 shares during the last quarter. Caitong International Asset Management Co. Ltd increased its stake in shares of Sotera Health by 33.1% in the second quarter. Caitong International Asset Management Co. Ltd now owns 3,583 shares of the company’s stock worth $40,000 after acquiring an additional 892 shares during the last quarter. Teacher Retirement System of Texas increased its stake in shares of Sotera Health by 4.1% in the second quarter. Teacher Retirement System of Texas now owns 23,707 shares of the company’s stock worth $264,000 after acquiring an additional 933 shares during the last quarter. Principal Financial Group Inc. increased its stake in shares of Sotera Health by 0.3% in the first quarter. Principal Financial Group Inc. now owns 352,388 shares of the company’s stock worth $4,109,000 after acquiring an additional 1,037 shares during the last quarter. Finally, Optimize Financial Inc increased its stake in shares of Sotera Health by 7.7% in the first quarter. Optimize Financial Inc now owns 14,545 shares of the company’s stock worth $170,000 after acquiring an additional 1,041 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Price Performance

Shares of NASDAQ:SHC opened at $16.61 on Tuesday. Sotera Health has a one year low of $9.53 and a one year high of $17.15. The stock has a fifty day moving average of $16.14 and a 200-day moving average of $13.66. The company has a market capitalization of $4.72 billion, a PE ratio of 207.65 and a beta of 1.82. The company has a debt-to-equity ratio of 4.49, a quick ratio of 2.23 and a current ratio of 2.47.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.03. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. The company had revenue of $294.34 million for the quarter, compared to the consensus estimate of $275.81 million. During the same period in the previous year, the business earned $0.19 EPS. The company’s revenue was up 6.4% on a year-over-year basis. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. As a group, equities analysts anticipate that Sotera Health will post 0.61 EPS for the current fiscal year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.